• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接触因子依赖性途径的血浆抑制剂。

Plasma inhibitors of the Hageman factor dependent pathways.

作者信息

Schreiber A D

出版信息

Semin Thromb Hemost. 1976 Jul;3(1):32-51.

PMID:799348
Abstract

The Hageman factor dependent pathways are influenced by several control proteins which modulate the extent of activation and biologic activity of these enzyme substrates (Fig. 1). C1 INH plays a prominent role by acting at the common initiating step for all three Hageman factor dependent systems and its deficiency produces disease in man. Alpha-2 macroglobulin appears to play an important role in the fibrinolytic sequence, having potent activity towards both plasminogen activator and plasmin. Antithrombin most prominently influences the state of activation of the coagulation sequence by regulating the enzymatic activities of activated Factors XI, IX and X and, most importantly, that of thrombin. Significantly, deficiency of antithrombin results in increased thrombosis in man.

摘要

接触因子依赖性途径受几种调控蛋白的影响,这些调控蛋白可调节这些酶底物的激活程度和生物学活性(图1)。C1抑制因子通过作用于所有三种接触因子依赖性系统的共同起始步骤发挥重要作用,其缺乏会在人类中引发疾病。α2巨球蛋白似乎在纤维蛋白溶解序列中发挥重要作用,对纤溶酶原激活剂和纤溶酶均具有强大活性。抗凝血酶通过调节活化的因子Ⅺ、Ⅸ和Ⅹ的酶活性,最重要的是调节凝血酶的酶活性,最显著地影响凝血序列的激活状态。值得注意的是,抗凝血酶缺乏会导致人类血栓形成增加。

相似文献

1
Plasma inhibitors of the Hageman factor dependent pathways.接触因子依赖性途径的血浆抑制剂。
Semin Thromb Hemost. 1976 Jul;3(1):32-51.
2
Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.弗莱彻因子缺乏症。由于缺乏前激肽释放酶导致哈格曼因子激活速率降低,伴有凝血、纤维蛋白溶解、趋化活性和激肽生成异常。
J Clin Invest. 1974 Feb;53(2):622-33. doi: 10.1172/JCI107597.
3
The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.易发生血栓形成的患者群体中的止血平衡。特别提及心肌梗死患者的纤维蛋白溶解。
Dan Med Bull. 1990 Jun;37(3):210-34.
4
The Hageman factor dependent pathways of coagulation, fibrinolysis, and kinin-generation.接触因子依赖的凝血、纤维蛋白溶解和激肽生成途径。
Semin Thromb Hemost. 1976 Jul;3(1):1-26. doi: 10.1055/s-0028-1087162.
5
[Factor XII (HAGEMAN FACTOR)].[凝血因子 XII(哈格曼因子)]
Folia Haematol Int Mag Klin Morphol Blutforsch. 1978;105(1):1-19.
6
Control of coagulation and fibrinolysis by plasma proteinase inhibitors.
Behring Inst Mitt. 1983 Aug(73):56-65.
7
The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments.哈格曼因子(因子 XII)及哈格曼因子片段对纤溶酶原的激活作用。
J Clin Invest. 1978 Jul;62(1):54-60. doi: 10.1172/JCI109113.
8
Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation.C1抑制物对凝血因子片段激活凝血、纤维蛋白溶解和激肽生成的抑制作用。
J Clin Invest. 1973 Jun;52(6):1402-9. doi: 10.1172/JCI107313.
9
Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.急性缺血性心脏病患者的纤维蛋白溶解。特别提及组织型纤溶酶原激活剂治疗对纤维蛋白溶解、凝血和补体途径的全身影响。
Dan Med Bull. 1993 Sep;40(4):383-408.
10
Hageman-factor-dependent coagulation, fibrinolysis, and kinin generation.哈格曼因子依赖性凝血、纤维蛋白溶解和激肽生成。
Transplant Proc. 1974 Mar;6(1):39-45.